Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXD11
|
ENSG00000128713.11 | homeobox D11 |
HOXA11
|
ENSG00000005073.5 | homeobox A11 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_176971216_176971605 | HOXD11 | 604 | 0.475731 | -0.67 | 4.9e-02 | Click! |
chr2_176971683_176972255 | HOXD11 | 45 | 0.924613 | -0.51 | 1.6e-01 | Click! |
chr2_176972526_176972677 | HOXD11 | 587 | 0.397193 | 0.17 | 6.5e-01 | Click! |
chr2_176969688_176969839 | HOXD11 | 2251 | 0.126484 | -0.08 | 8.4e-01 | Click! |
chr2_176969448_176969655 | HOXD11 | 2463 | 0.118195 | -0.04 | 9.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_120168336_120168615 | 0.31 |
FSTL1 |
follistatin-like 1 |
1363 |
0.54 |
chr3_106063956_106064334 | 0.30 |
ENSG00000200610 |
. |
170599 |
0.04 |
chr4_119755136_119755442 | 0.28 |
SEC24D |
SEC24 family member D |
2004 |
0.43 |
chr2_7152423_7152574 | 0.27 |
RNF144A |
ring finger protein 144A |
15427 |
0.23 |
chr3_32010054_32010475 | 0.25 |
OSBPL10 |
oxysterol binding protein-like 10 |
12528 |
0.2 |
chr7_14020163_14020323 | 0.25 |
ETV1 |
ets variant 1 |
5823 |
0.29 |
chr12_11325045_11325196 | 0.24 |
RP11-785H5.2 |
|
1168 |
0.4 |
chr3_29327656_29328192 | 0.24 |
RBMS3-AS3 |
RBMS3 antisense RNA 3 |
4293 |
0.26 |
chr8_42063953_42065062 | 0.23 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr4_86700210_86700446 | 0.23 |
ARHGAP24 |
Rho GTPase activating protein 24 |
469 |
0.88 |
chr6_128529501_128529738 | 0.23 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
113707 |
0.07 |
chr6_53928552_53928746 | 0.23 |
MLIP-AS1 |
MLIP antisense RNA 1 |
15875 |
0.2 |
chr7_134465735_134465936 | 0.22 |
CALD1 |
caldesmon 1 |
1406 |
0.57 |
chr13_74636535_74636686 | 0.22 |
KLF12 |
Kruppel-like factor 12 |
67424 |
0.15 |
chr7_116164164_116164509 | 0.21 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
503 |
0.76 |
chr2_151385576_151386025 | 0.21 |
RND3 |
Rho family GTPase 3 |
9725 |
0.33 |
chr8_95816216_95816367 | 0.21 |
INTS8 |
integrator complex subunit 8 |
9248 |
0.16 |
chr2_134432207_134432889 | 0.21 |
ENSG00000200708 |
. |
78886 |
0.11 |
chr10_112258642_112259418 | 0.21 |
DUSP5 |
dual specificity phosphatase 5 |
1434 |
0.41 |
chr7_76958008_76958159 | 0.21 |
GSAP |
gamma-secretase activating protein |
1601 |
0.47 |
chr3_183893852_183894003 | 0.21 |
AP2M1 |
adaptor-related protein complex 2, mu 1 subunit |
639 |
0.55 |
chr8_23711697_23711872 | 0.20 |
STC1 |
stanniocalcin 1 |
40 |
0.98 |
chr5_54456456_54456818 | 0.20 |
GPX8 |
glutathione peroxidase 8 (putative) |
639 |
0.58 |
chr8_8745358_8745509 | 0.19 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
5722 |
0.22 |
chr7_18549207_18549425 | 0.19 |
HDAC9 |
histone deacetylase 9 |
380 |
0.92 |
chr4_41178199_41178352 | 0.19 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
38200 |
0.15 |
chr17_15281303_15281454 | 0.19 |
ENSG00000239888 |
. |
30323 |
0.15 |
chr5_110846365_110846666 | 0.18 |
STARD4-AS1 |
STARD4 antisense RNA 1 |
1409 |
0.37 |
chr5_54456050_54456451 | 0.18 |
GPX8 |
glutathione peroxidase 8 (putative) |
252 |
0.86 |
chr1_218521749_218522027 | 0.18 |
TGFB2 |
transforming growth factor, beta 2 |
2311 |
0.31 |
chr16_83377985_83378136 | 0.18 |
RP11-543N12.1 |
|
53532 |
0.15 |
chr5_50040977_50041222 | 0.18 |
PARP8 |
poly (ADP-ribose) polymerase family, member 8 |
77708 |
0.12 |
chr2_160291322_160291473 | 0.18 |
BAZ2B |
bromodomain adjacent to zinc finger domain, 2B |
1936 |
0.41 |
chr7_134464463_134465343 | 0.18 |
CALD1 |
caldesmon 1 |
474 |
0.89 |
chr5_155754820_155754971 | 0.18 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
1128 |
0.68 |
chr14_51242372_51242693 | 0.18 |
NIN |
ninein (GSK3B interacting protein) |
9019 |
0.17 |
chr7_94029074_94029225 | 0.17 |
COL1A2 |
collagen, type I, alpha 2 |
5276 |
0.3 |
chr8_49292577_49292728 | 0.17 |
ENSG00000252710 |
. |
72062 |
0.13 |
chr5_35130063_35130359 | 0.17 |
PRLR |
prolactin receptor |
235 |
0.95 |
chr15_71054590_71054766 | 0.17 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
1091 |
0.55 |
chr8_16612533_16612758 | 0.17 |
ENSG00000264092 |
. |
108360 |
0.07 |
chr4_138452878_138453572 | 0.17 |
PCDH18 |
protocadherin 18 |
340 |
0.94 |
chrX_43832059_43832293 | 0.17 |
NDP |
Norrie disease (pseudoglioma) |
574 |
0.81 |
chr15_61520624_61520983 | 0.16 |
RORA |
RAR-related orphan receptor A |
715 |
0.73 |
chr15_25915762_25916070 | 0.16 |
ATP10A |
ATPase, class V, type 10A |
24056 |
0.19 |
chr10_133793669_133793880 | 0.16 |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
1653 |
0.46 |
chr13_36047635_36048256 | 0.16 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
2887 |
0.26 |
chr3_112358713_112358917 | 0.16 |
CCDC80 |
coiled-coil domain containing 80 |
1301 |
0.54 |
chr8_58715313_58715521 | 0.16 |
FAM110B |
family with sequence similarity 110, member B |
191696 |
0.03 |
chr1_92329705_92329906 | 0.16 |
TGFBR3 |
transforming growth factor, beta receptor III |
2655 |
0.31 |
chr3_49538097_49538499 | 0.16 |
DAG1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
30546 |
0.11 |
chr17_40561693_40562104 | 0.16 |
ENSG00000221020 |
. |
10871 |
0.11 |
chr20_50550896_50551117 | 0.16 |
ENSG00000263659 |
. |
6366 |
0.22 |
chr7_10491618_10491769 | 0.16 |
ENSG00000212422 |
. |
229269 |
0.02 |
chr7_121514140_121514423 | 0.16 |
PTPRZ1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
866 |
0.74 |
chr1_178310607_178310919 | 0.16 |
RASAL2 |
RAS protein activator like 2 |
157 |
0.97 |
chr13_50649761_50650212 | 0.16 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
6321 |
0.18 |
chr2_207873339_207873490 | 0.16 |
CPO |
carboxypeptidase O |
69136 |
0.11 |
chr16_80181289_80181449 | 0.15 |
DYNLRB2 |
dynein, light chain, roadblock-type 2 |
393262 |
0.01 |
chr17_46654170_46654895 | 0.15 |
HOXB3 |
homeobox B3 |
2094 |
0.12 |
chr10_17275327_17275794 | 0.15 |
RP11-124N14.3 |
|
1272 |
0.37 |
chr1_88150758_88150976 | 0.15 |
ENSG00000199318 |
. |
231811 |
0.02 |
chr9_20570670_20570821 | 0.15 |
ENSG00000252324 |
. |
5471 |
0.24 |
chr7_82072002_82072462 | 0.15 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
799 |
0.78 |
chr4_38870502_38870773 | 0.15 |
ENSG00000207944 |
. |
984 |
0.38 |
chr10_17151338_17151489 | 0.15 |
CUBN |
cubilin (intrinsic factor-cobalamin receptor) |
18423 |
0.23 |
chr11_31826043_31826338 | 0.15 |
PAX6 |
paired box 6 |
2279 |
0.32 |
chr6_122791067_122791230 | 0.15 |
SERINC1 |
serine incorporator 1 |
1819 |
0.33 |
chr8_22342638_22342826 | 0.15 |
PPP3CC |
protein phosphatase 3, catalytic subunit, gamma isozyme |
9627 |
0.15 |
chr13_98859156_98859307 | 0.15 |
ENSG00000263399 |
. |
1547 |
0.31 |
chr22_29107845_29108091 | 0.15 |
CHEK2 |
checkpoint kinase 2 |
25 |
0.97 |
chr4_38754112_38754445 | 0.15 |
ENSG00000222230 |
. |
6235 |
0.19 |
chr17_45352801_45353270 | 0.15 |
ENSG00000238419 |
. |
16249 |
0.13 |
chr1_57042188_57042339 | 0.15 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
2978 |
0.37 |
chr13_47470589_47471243 | 0.15 |
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
253 |
0.95 |
chr1_240262074_240262225 | 0.15 |
FMN2 |
formin 2 |
6969 |
0.27 |
chr8_128751469_128751888 | 0.15 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
3201 |
0.34 |
chr16_4069505_4069681 | 0.15 |
RP11-462G12.4 |
|
12420 |
0.19 |
chr10_33239282_33239433 | 0.15 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
5234 |
0.31 |
chr11_132813237_132813595 | 0.15 |
OPCML |
opioid binding protein/cell adhesion molecule-like |
150 |
0.98 |
chr6_45523951_45524153 | 0.14 |
ENSG00000252738 |
. |
89789 |
0.09 |
chr4_53411844_53412014 | 0.14 |
ENSG00000239068 |
. |
35750 |
0.18 |
chr17_57860675_57860960 | 0.14 |
RP11-619I22.1 |
|
1357 |
0.39 |
chr8_108441987_108442138 | 0.14 |
ANGPT1 |
angiopoietin 1 |
65161 |
0.15 |
chr6_26743586_26743955 | 0.14 |
ZNF322 |
zinc finger protein 322 |
83790 |
0.08 |
chr3_175389807_175390608 | 0.14 |
ENSG00000201648 |
. |
62940 |
0.12 |
chr3_56501298_56501701 | 0.14 |
ERC2 |
ELKS/RAB6-interacting/CAST family member 2 |
892 |
0.73 |
chr2_190044119_190044339 | 0.14 |
COL5A2 |
collagen, type V, alpha 2 |
376 |
0.9 |
chr18_32290517_32290846 | 0.14 |
DTNA |
dystrobrevin, alpha |
420 |
0.9 |
chr11_121968787_121969071 | 0.14 |
ENSG00000207971 |
. |
1623 |
0.3 |
chr3_116755274_116755493 | 0.14 |
ENSG00000200372 |
. |
71309 |
0.12 |
chr6_112192884_112193487 | 0.14 |
FYN |
FYN oncogene related to SRC, FGR, YES |
1055 |
0.66 |
chr16_50400842_50400993 | 0.14 |
RP11-21B23.1 |
|
1574 |
0.3 |
chr19_47679771_47679978 | 0.14 |
SAE1 |
SUMO1 activating enzyme subunit 1 |
45722 |
0.09 |
chr5_111090218_111090459 | 0.14 |
NREP |
neuronal regeneration related protein |
1610 |
0.42 |
chr6_82956530_82956750 | 0.14 |
IBTK |
inhibitor of Bruton agammaglobulinemia tyrosine kinase |
831 |
0.72 |
chr11_101918556_101918783 | 0.14 |
C11orf70 |
chromosome 11 open reading frame 70 |
480 |
0.77 |
chr12_86228304_86228474 | 0.14 |
RASSF9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
1959 |
0.44 |
chr11_12701419_12701570 | 0.14 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
4444 |
0.33 |
chr3_151989912_151990063 | 0.14 |
MBNL1-AS1 |
MBNL1 antisense RNA 1 |
2643 |
0.28 |
chr6_5752341_5752548 | 0.14 |
RP1-256G22.2 |
|
56939 |
0.16 |
chr10_96121693_96122003 | 0.14 |
NOC3L |
nucleolar complex associated 3 homolog (S. cerevisiae) |
137 |
0.96 |
chr3_125086964_125087115 | 0.14 |
ZNF148 |
zinc finger protein 148 |
7054 |
0.21 |
chr5_57751342_57751690 | 0.14 |
PLK2 |
polo-like kinase 2 |
4571 |
0.26 |
chr12_5368313_5368577 | 0.14 |
NTF3 |
neurotrophin 3 |
172834 |
0.03 |
chr12_107773843_107774162 | 0.14 |
ENSG00000200897 |
. |
5478 |
0.28 |
chr11_122050333_122050506 | 0.14 |
ENSG00000207994 |
. |
27403 |
0.16 |
chr2_14776009_14776160 | 0.14 |
AC011897.1 |
Uncharacterized protein |
869 |
0.66 |
chr8_13371978_13372169 | 0.14 |
DLC1 |
deleted in liver cancer 1 |
201 |
0.95 |
chr21_35501672_35502212 | 0.13 |
SLC5A3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
56072 |
0.12 |
chr1_99730395_99730700 | 0.13 |
LPPR4 |
Lipid phosphate phosphatase-related protein type 4 |
699 |
0.82 |
chr8_54817773_54817967 | 0.13 |
ENSG00000200528 |
. |
9409 |
0.19 |
chr5_14147401_14147552 | 0.13 |
TRIO |
trio Rho guanine nucleotide exchange factor |
3647 |
0.38 |
chr1_115711115_115711431 | 0.13 |
TSPAN2 |
tetraspanin 2 |
79152 |
0.1 |
chr12_59310321_59310512 | 0.13 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2052 |
0.37 |
chr6_98298640_98298796 | 0.13 |
ENSG00000238367 |
. |
173689 |
0.04 |
chr1_49344464_49344615 | 0.13 |
BEND5 |
BEN domain containing 5 |
101949 |
0.08 |
chr1_116918472_116918782 | 0.13 |
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
2138 |
0.27 |
chr9_128463484_128463681 | 0.13 |
MAPKAP1 |
mitogen-activated protein kinase associated protein 1 |
5874 |
0.28 |
chr1_221509112_221509492 | 0.13 |
DUSP10 |
dual specificity phosphatase 10 |
401500 |
0.01 |
chr6_152701268_152701555 | 0.13 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
270 |
0.91 |
chr21_34181326_34181477 | 0.13 |
C21orf62 |
chromosome 21 open reading frame 62 |
1373 |
0.37 |
chr2_216301006_216301560 | 0.13 |
AC012462.1 |
|
307 |
0.57 |
chr20_42647159_42647526 | 0.13 |
ENSG00000241229 |
. |
11454 |
0.23 |
chr10_60859439_60859590 | 0.13 |
PHYHIPL |
phytanoyl-CoA 2-hydroxylase interacting protein-like |
76836 |
0.12 |
chr13_98532442_98532896 | 0.13 |
ENSG00000238407 |
. |
5394 |
0.31 |
chr12_13328389_13328540 | 0.13 |
EMP1 |
epithelial membrane protein 1 |
21186 |
0.21 |
chr22_50680951_50681194 | 0.13 |
TUBGCP6 |
tubulin, gamma complex associated protein 6 |
1921 |
0.15 |
chr6_25276056_25276207 | 0.13 |
LRRC16A |
leucine rich repeat containing 16A |
3525 |
0.2 |
chr15_80364981_80365385 | 0.13 |
ZFAND6 |
zinc finger, AN1-type domain 6 |
251 |
0.94 |
chr10_17554144_17554295 | 0.13 |
ST8SIA6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
57890 |
0.12 |
chr4_152148275_152148426 | 0.13 |
SH3D19 |
SH3 domain containing 19 |
600 |
0.77 |
chr1_164532740_164533333 | 0.13 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
994 |
0.67 |
chr10_376062_376213 | 0.13 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
671 |
0.73 |
chrX_74966247_74966822 | 0.13 |
MAGEE2 |
melanoma antigen family E, 2 |
38545 |
0.23 |
chr7_129283433_129283584 | 0.13 |
NRF1 |
nuclear respiratory factor 1 |
13599 |
0.23 |
chr4_114897314_114897610 | 0.13 |
ARSJ |
arylsulfatase family, member J |
2690 |
0.37 |
chr2_189840264_189840425 | 0.13 |
COL3A1 |
collagen, type III, alpha 1 |
1245 |
0.47 |
chr17_15553766_15553944 | 0.13 |
RP11-640I15.1 |
|
1049 |
0.32 |
chr9_2838300_2838770 | 0.13 |
KIAA0020 |
KIAA0020 |
5706 |
0.3 |
chr2_192547837_192547988 | 0.13 |
NABP1 |
nucleic acid binding protein 1 |
4196 |
0.34 |
chr10_63808619_63808770 | 0.13 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
276 |
0.95 |
chr11_86512357_86512728 | 0.13 |
PRSS23 |
protease, serine, 23 |
957 |
0.7 |
chr4_114216807_114216958 | 0.13 |
ANK2 |
ankyrin 2, neuronal |
2744 |
0.39 |
chr1_33546320_33546691 | 0.13 |
ADC |
arginine decarboxylase |
209 |
0.94 |
chr21_17792302_17792515 | 0.13 |
ENSG00000207638 |
. |
119001 |
0.06 |
chr6_127836184_127836541 | 0.13 |
SOGA3 |
SOGA family member 3 |
1397 |
0.51 |
chr2_66670252_66670507 | 0.13 |
MEIS1 |
Meis homeobox 1 |
282 |
0.85 |
chr7_94025506_94025990 | 0.12 |
COL1A2 |
collagen, type I, alpha 2 |
1875 |
0.46 |
chr9_18476160_18476529 | 0.12 |
ADAMTSL1 |
ADAMTS-like 1 |
2113 |
0.45 |
chr10_4174092_4174250 | 0.12 |
KLF6 |
Kruppel-like factor 6 |
346698 |
0.01 |
chr15_73901500_73901651 | 0.12 |
NPTN |
neuroplastin |
23529 |
0.22 |
chr4_142250581_142250732 | 0.12 |
ENSG00000238695 |
. |
31624 |
0.23 |
chr15_58600153_58600304 | 0.12 |
ALDH1A2 |
aldehyde dehydrogenase 1 family, member A2 |
28766 |
0.22 |
chr11_23103600_23103751 | 0.12 |
CCDC179 |
coiled-coil domain containing 179 |
221703 |
0.02 |
chr8_103135084_103136044 | 0.12 |
NCALD |
neurocalcin delta |
614 |
0.72 |
chr6_157116874_157117032 | 0.12 |
RP11-230C9.3 |
|
15364 |
0.19 |
chr2_175710954_175711206 | 0.12 |
CHN1 |
chimerin 1 |
53 |
0.98 |
chr15_86162614_86163207 | 0.12 |
RP11-815J21.3 |
|
8010 |
0.15 |
chr2_205890097_205890340 | 0.12 |
PARD3B |
par-3 family cell polarity regulator beta |
479495 |
0.01 |
chr11_1061075_1061262 | 0.12 |
MUC2 |
mucin 2, oligomeric mucus/gel-forming |
13707 |
0.16 |
chr13_50020768_50020928 | 0.12 |
AL136218.1 |
Sarcoma antigen NY-SAR-79; Uncharacterized protein |
294 |
0.86 |
chr10_61997707_61998072 | 0.12 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
62351 |
0.15 |
chr5_54795571_54795722 | 0.12 |
ENSG00000265135 |
. |
9108 |
0.22 |
chr2_74606600_74607395 | 0.12 |
DCTN1 |
dynactin 1 |
413 |
0.73 |
chr12_123599881_123600060 | 0.12 |
PITPNM2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
4928 |
0.21 |
chr8_135563902_135564089 | 0.12 |
ZFAT |
zinc finger and AT hook domain containing |
41570 |
0.18 |
chr3_57580599_57580768 | 0.12 |
ARF4 |
ADP-ribosylation factor 4 |
2369 |
0.17 |
chr21_17652021_17652264 | 0.12 |
ENSG00000201025 |
. |
4947 |
0.35 |
chr8_103664786_103665058 | 0.12 |
KLF10 |
Kruppel-like factor 10 |
1681 |
0.44 |
chr17_13265618_13265967 | 0.12 |
ENSG00000266115 |
. |
137853 |
0.05 |
chr17_32582682_32583141 | 0.12 |
AC005549.3 |
Uncharacterized protein |
605 |
0.41 |
chr8_108518030_108518181 | 0.12 |
ANGPT1 |
angiopoietin 1 |
7822 |
0.33 |
chr3_52705556_52705775 | 0.12 |
PBRM1 |
polybromo 1 |
6918 |
0.09 |
chr11_114311191_114311379 | 0.12 |
REXO2 |
RNA exonuclease 2 |
442 |
0.82 |
chr9_133814218_133814626 | 0.12 |
FIBCD1 |
fibrinogen C domain containing 1 |
33 |
0.97 |
chr7_94035982_94036133 | 0.12 |
COL1A2 |
collagen, type I, alpha 2 |
12184 |
0.27 |
chr6_147850870_147851021 | 0.12 |
SAMD5 |
sterile alpha motif domain containing 5 |
20583 |
0.29 |
chr18_56528511_56528662 | 0.12 |
ZNF532 |
zinc finger protein 532 |
1246 |
0.46 |
chr17_12452739_12453131 | 0.12 |
MYOCD |
myocardin |
116371 |
0.06 |
chr16_65154468_65154619 | 0.12 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
1290 |
0.65 |
chr16_58162054_58162435 | 0.12 |
C16orf80 |
chromosome 16 open reading frame 80 |
1021 |
0.33 |
chr6_131382789_131382971 | 0.12 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
836 |
0.75 |
chr9_21964953_21966022 | 0.12 |
C9orf53 |
chromosome 9 open reading frame 53 |
1650 |
0.31 |
chr3_150131821_150132388 | 0.12 |
TSC22D2 |
TSC22 domain family, member 2 |
3308 |
0.35 |
chr2_213976639_213976790 | 0.12 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
36639 |
0.21 |
chr3_16551030_16551181 | 0.12 |
RFTN1 |
raftlin, lipid raft linker 1 |
3306 |
0.33 |
chr4_169752801_169753072 | 0.12 |
PALLD |
palladin, cytoskeletal associated protein |
220 |
0.9 |
chrY_14899611_14899762 | 0.12 |
USP9Y |
ubiquitin specific peptidase 9, Y-linked |
59284 |
0.16 |
chr7_100777700_100777901 | 0.12 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
7421 |
0.1 |
chr11_84844293_84844464 | 0.12 |
DLG2 |
discs, large homolog 2 (Drosophila) |
211 |
0.97 |
chr3_89163237_89163857 | 0.12 |
EPHA3 |
EPH receptor A3 |
6721 |
0.35 |
chr17_67137803_67138011 | 0.12 |
ABCA6 |
ATP-binding cassette, sub-family A (ABC1), member 6 |
108 |
0.97 |
chr21_17652326_17652785 | 0.12 |
ENSG00000201025 |
. |
4534 |
0.36 |
chr2_227653875_227654026 | 0.12 |
IRS1 |
insulin receptor substrate 1 |
10525 |
0.21 |
chr4_178235041_178235192 | 0.12 |
NEIL3 |
nei endonuclease VIII-like 3 (E. coli) |
4126 |
0.26 |
chr9_131316906_131317348 | 0.12 |
SPTAN1 |
spectrin, alpha, non-erythrocytic 1 |
2258 |
0.18 |
chr6_28922002_28922229 | 0.12 |
C6orf100 |
chromosome 6 open reading frame 100 |
10461 |
0.12 |
chr3_191048468_191048928 | 0.12 |
UTS2B |
urotensin 2B |
373 |
0.85 |
chr1_179111271_179111703 | 0.12 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
692 |
0.72 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.1 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.0 | 0.1 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.0 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.2 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.3 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.0 | GO:0070100 | apoptotic process involved in luteolysis(GO:0061364) regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0002913 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.0 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 0.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.3 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.0 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.0 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0032823 | natural killer cell differentiation(GO:0001779) regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.0 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0044217 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 1.0 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.0 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.4 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.0 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |